MP Biomedicals Acquires New Zealand Protein Biologics Company

SANTA ANA, Calif.–MP Biomedicals LLC announced today that it has signed a definitive agreement to acquire the assets of ICPbio International LTD., an Auckland, New Zealand based protein biologics manufacturing company, subject to normal closing adjustments. This acquisition places MP Biomedicals in a strong position to pursue sales and distribution of serum protein products used in research and manufacturing in the Biopharmaceutical, In vitro diagnostic and Biotech sectors.

“We feel that this world class protein separation platform provides the manufacturing organization resources needed for MP Biomedicals to more fully serve customer demands for quality, low-risk serum protein materials collected and produced in the pristine environment of New Zealand.”

Milan Panic, Chairman and CEO of MP Biomedicals, said, “We feel that this world class protein separation platform provides the manufacturing organization resources needed for MP Biomedicals to more fully serve customer demands for quality, low-risk serum protein materials collected and produced in the pristine environment of New Zealand.”

ICPbio Ltd. utilizes a state of the art chromatographic extraction which ensures high purity, intact proteins, and processes without the denaturing effect of conventional precipitation methods of manufacture. Furthermore, the technology and quality systems ensure a high level of process control and product consistency, meeting the stringent demands of the bio-pharmaceutical industry. The product line includes Thrombin, Transferrin, Albumin and IGg. MP will distribute and sell these products worldwide.

About MP Biomedicals – MP Biomedicals manufactures and sells more than 55,000 products and is one of the only companies in the industry to offer a comprehensive line of life science, fine chemical and diagnostic products.

MP Biomedicals is a world-wide corporation, with ISO-certified and FDA-approved manufacturing and distribution facilities throughout the globe and headquartered in Southern California. A vast network of global distributors and satellite facilities and offices throughout Europe, Asia, Australia and the Americas assures customers top quality products delivered when and where needed.

MP Biomedicals was founded in 1959 by Milan Panic, the American businessman of Serbian origin, former prime minister of Yugoslavia (1992-1993).

< | >